Skip to main content
See every side of every news story
Published loading...Updated

Biden Officials Knew About, Downplayed Risks From COVID-19 Vaccines, Senate Report Claims

  • On May 22, 2025, the FDA directed Pfizer and Moderna to include additional warnings on their COVID-19 vaccine labels regarding the rare occurrence of heart inflammation in males aged 16 to 25.
  • This action follows 2023 FDA safety monitoring and studies that identified myocarditis and pericarditis as rare side effects linked to mRNA vaccines in this age group.
  • The updated vaccine labels indicate that males aged 16 to 25 experience myocarditis or pericarditis at a rate of 38 cases per million doses, and the CDC notes that most of these heart inflammation cases arise shortly after vaccination and generally resolve quickly.
  • FDA spokesperson Andrew Nixon stated that it is crucial for the public to have full clarity regarding the safety and effectiveness of COVID vaccines, as Pfizer and Moderna are given 30 days to respond to the FDA’s directive.
  • The warning may increase awareness of vaccine risks among young males, though studies continue on possible long-term heart effects after myocarditis post-vaccination.
Insights by Ground AI

82 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 79% of the sources lean Right
79% Right

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

The National Desk broke the news in on Wednesday, May 21, 2025.
Sources are mostly out of (0)
News
For You
Search
BlindspotLocal